Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. scores highest on Anchor (63) and lowest on Price (2). Its PosiPenta is 41.18 out of 100, around the middle of similar companies.
On the Penta Grid this week, Indaptus Therapeutics, Inc. is Grid #497 of 837 in the Healthcare sector in United States, and Grid #2,763 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. | 41.18 | 2 | 41 | 50 | 49 | 63 |
| Carlsmed, Inc. | 45.64 | 16 | 31 | 78 | 40 | 64 |
| Avalo Therapeutics, Inc. | 42.70 | 35 | 32 | 25 | 70 | 51 |
| Orthofix Medical Inc. | 49.69 | 41 | 62 | 46 | 48 | 52 |
| Senseonics Holdings, Inc. | 39.33 | 15 | 30 | 73 | 24 | 54 |
| C4 Therapeutics, Inc. | 39.88 | 34 | 36 | 55 | 45 | 29 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.43 |
| P/B ratio | 30.81 |
EEarnings
| Trailing EPS | ₹-582.50 |
| Forward EPS | ₹-131.65 |
NNitro
| Price | 249.10 |
| 52-week high | 564.50 |
| 52-week low | 87.14 |
| Fall from 52-week high | 55.9% |
TTorque
| Return on equity (ROE) | -318.04% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.97 |
| Market cap | ₹3,319 Cr |
| Insider holding | 82.41% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Indaptus Therapeutics, Inc.'s PosiPenta score?
Indaptus Therapeutics, Inc.'s PosiPenta is 41.18 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Indaptus Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Indaptus Therapeutics, Inc. is Grid #497 of 837 in the Healthcare sector in United States, and Grid #2,763 of 4,000 in United States.
Which PosiPenta pillar is strongest for Indaptus Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 63 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Indaptus Therapeutics, Inc.?
Price (valuation), with a score of 2 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.